These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy. Celotti F, Durand T. Prostaglandins Other Lipid Mediat; 2003 Jul; 71(3-4):147-62. PubMed ID: 14518558 [Abstract] [Full Text] [Related]
8. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs. Charlier C, Michaux C. Eur J Med Chem; 2003 Jul; 38(7-8):645-59. PubMed ID: 12932896 [Abstract] [Full Text] [Related]
16. COX-2 inhibitors. What is their place? McGettigan P. Aust Fam Physician; 2000 Sep; 29(9):847-52. PubMed ID: 11008387 [Abstract] [Full Text] [Related]
18. Novel non-steroidal anti-inflammatory drugs: what we have learned from animal studies. Coruzzi G, Menozzi A, Dobrilla G. Curr Drug Targets Inflamm Allergy; 2004 Mar; 3(1):43-61. PubMed ID: 15032641 [Abstract] [Full Text] [Related]